Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 5 | 9 | 7 | 6 | 7 |
| Gross Profit | 5 | 9 | 7 | 6 | 7 |
| Operating Expenses | 2,472 | 1,625 | 826 | 539 | 519 |
| Operating Income | -2,467 | -1,616 | -819 | -533 | -512 |
| Other Income | 20 | -41 | 26 | -6 | -71 |
| Pre-tax Income | -2,447 | -1,657 | -794 | -539 | -583 |
| Income Tax | -4 | 1 | -1 | -5 | -1 |
| Net Income Continuous | -2,444 | -1,658 | -793 | -534 | -582 |
| Net Income | $-2,444 | $-1,658 | $-793 | $-534 | $-582 |
| EPS Basic Total Ops | -0.50 | -0.52 | -0.25 | -0.27 | -0.29 |
| EPS Basic Continuous Ops | -0.50 | -0.52 | -0.25 | -0.27 | -0.29 |
| EPS Diluted Total Ops | -0.50 | -0.52 | -0.25 | -0.27 | -0.29 |
| EPS Diluted Continuous Ops | -0.50 | -0.52 | -0.25 | -0.27 | -0.29 |
| EBITDA(a) | $-2,464 | $-1,614 | $-817 | $-530 | $-510 |